何氏眼科联合茅台招华发起一支健康科技产业基金

投资界11-01

投资界（ID：pedaily2012）消息，10月29日，何氏眼科发布公告，公司与深圳市招商国协贰号股权投资基金管理有限公司（简称“招商局资本”）及茅台招华（贵州）产业发展基金合伙企业（有限合伙）共同投资设立招华（贵州）健康科技产业发展基金合伙企业（有限合伙）（名称最终以工商注册为准）。基金规模7.97亿元，招商局资本担任基金管理人。基金以眼健康为切入点，主要投资于新一代医疗健康、食疗营养以及合成...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2480049160?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-01 11:12","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2480049160","market":"sh","top_or_hot":-1,"title":"何氏眼科联合茅台招华发起一支健康科技产业基金","media":"投资界","content":"<div>\n<p>投资界（ID：pedaily2012）消息，10月29日，何氏眼科发布公告，公司与深圳市招商国协贰号股权投资基金管理有限公司（简称“招商局资本”）及茅台招华（贵州）产业发展基金合伙企业（有限合伙）共同投资设立招华（贵州）健康科技产业发展基金合伙企业（有限合伙）（名称最终以工商注册为准）。基金规模7.97亿元，招商局资本担任基金管理人。基金以眼健康为切入点，主要投资于新一代医疗健康、食疗营养以及合成...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101114808ab8f8326&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>何氏眼科联合茅台招华发起一支健康科技产业基金</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n何氏眼科联合茅台招华发起一支健康科技产业基金\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-01 11:12 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101114808ab8f8326&s=b><strong>投资界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>投资界（ID：pedaily2012）消息，10月29日，何氏眼科发布公告，公司与深圳市招商国协贰号股权投资基金管理有限公司（简称“招商局资本”）及茅台招华（贵州）产业发展基金合伙企业（有限合伙）共同投资设立招华（贵州）健康科技产业发展基金合伙企业（有限合伙）（名称最终以工商注册为准）。基金规模7.97亿元，招商局资本担任基金管理人。基金以眼健康为切入点，主要投资于新一代医疗健康、食疗营养以及合成...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101114808ab8f8326&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0187","symbol_name":"一线龙头","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101114808ab8f8326&s=b","article_id":"2480049160","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101114808ab8f8326&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2480049160","pubTimestamp":1730430720,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"投资界消息，10月29日，何氏眼科发布公告，公司与深圳市招商国协贰号股权投资基金管理有限公司及茅台招华（贵州）产业发展基金合伙企业共同投资设立招华（贵州）健康科技产业发展基金合伙企业。基金规模7.97亿元，招商局资本担任基金管理人。基金以眼健康为切入点，主要投资于新一代医疗健康、食疗营养以及合成生物等领域。官网显示，何氏眼科创办于1995年，是集医教研于一体，采用三级眼健康医疗服务模式的集团型连锁眼科服务机构。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"301103":"何氏眼科","600519":"贵州茅台","BK0187":"一线龙头","LU0823426308.USD":"法巴中国股票基金","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0348814723.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"A\" (USD) INC  NC","LU0211977185.USD":"EASTSPRING INVESTMENTS GREATER CHINA EQUITY \"A\" ACC","LU0328353924.USD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) \"P\" (USD) ACC","LU0878005551.USD":"UBS (LUX) KEY SELEC ASIA ALLOCATION OPPORTUNITY (USD) \"P\" (USD) ACC","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","LU0051755006.USD":"摩根大通中国A (dist)","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU0370786039.SGD":"Fidelity Greater China A-SGD","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","IE00BMCWC346.EUR":"GUINNESS EMERGING MARKETS EQUITY INCOME \"C\" (EUR) ACC","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","BK0012":"证金概念","LU0052750758.USD":"富兰克林中国基金A Acc","BK0196":"行业龙头","LU0873338254.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) INC","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU0501845795.SGD":"瑞银大中华区股票基金P Acc SGD","BK0236":"卫生","LU0577902371.SGD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (SGD) ACC","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU0348816934.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (USD)","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0650527681.SGD":"Fidelity China Consumer A-SGD","LU0577902298.EUR":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (EUR) ACC","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0880133367.SGD":"UBS (LUX) EQUITY FUND CHINA OPPORTUNITY USD \"P\" (SGD) ACC","LU0048580855.USD":"富达大中华区A","LU0231483743.USD":"abrdn SICAV I - ALL CHINA SUSTAINABLE EQUITY \"A\" (USD) ACC","LU0577902538.SGD":"Fullerton Lux Funds - Asia Growth and Income Equities A Acc SGD","BK0028":"国家队","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU0577902454.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) ACC","LU0228659784.USD":"施罗德金砖四国基金","LU0594300179.USD":"FIDELITY CHINA CONSUMER \"A\" (USD) ACC","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","LU0072913022.USD":"UBS (LUX) EQUITY FUND -  GREATER CHINA \"P\" (USD) ACC","LU0348805143.USD":"ALLIANZ ENHANCED ALL CHINA EQUITY \"A\" (USD) INC","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC"},"translate_title":"He's Ophthalmology and Moutai Zhaohua launched a health technology industry fund","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"301103":1,"600519":1},"content_text":"投资界（ID：pedaily2012）消息，10月29日，何氏眼科发布公告，公司与深圳市招商国协贰号股权投资基金管理有限公司（简称“招商局资本”）及茅台招华（贵州）产业发展基金合伙企业（有限合伙）共同投资设立招华（贵州）健康科技产业发展基金合伙企业（有限合伙）（名称最终以工商注册为准）。基金规模7.97亿元，招商局资本担任基金管理人。基金以眼健康为切入点，主要投资于新一代医疗健康、食疗营养以及合成生物等领域。官网显示，何氏眼科创办于1995年，是集医教研于一体，采用三级眼健康医疗服务模式的集团型连锁眼科服务机构。截止2023年年末，公司拥有121家眼科服务机构，遍布辽宁、京津冀、长三角、成渝、粤港澳大湾区及海南等全国重点区域。招商局资本成立于2012年，是招商局集团与普洛斯的合营公司，专门从事另类投资与资产管理业务，运用招商局集团和普洛斯的网络优势和产业背景，在新能源、硬科技、生命科学、现代服务等领域寻求合作契机。点击获取更多LP资讯https://www.pedaily.cn/s104/本文来源投资界，原文：https://news.pedaily.cn/202411/542344.shtml","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2480049160"}